Login
03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Contraindicated
Fetal hypothyroidism
Contraindicated
Fetal hypothyroidism
| Farcodarone* : | |
| Type | Medicine Non Marketed |
| Originator | Cordarone Tablets |
| Agent | Mediterranean Pharmaceutical Company |
| Distributor | Mediterranean Pharmaceutical Company |
| Laboratory | Pharco Pharmaceuticals |
| Responsible Party | Pharco Pharmaceuticals |
| Origin | Egypt |
| Manufacturer | Pharco |
| Manufacturing Type | G |
| Origin | Egypt |
| ATC | C01BD01 |
Farcodarone* :
Farcodarone* :
Farcodarone* :
Farcodarone* :
Farcodarone* :
| Frequency | Percentage |
|---|---|
| Very Common | ≥ 1/10 |
| Common | ≥ 1/100 - < 1/10 |
| Uncommon | ≥ 1/1,000 - < 1/100 |
| Rare | ≥ 1/10,000 - < 1/1,000 |
| Very Rare | < 1/10,000 |
| Unknown | Cannot be Estimated |
| Effect | Frequency |
|---|---|
| Adult respiratory distress syndrome | Very rare |
| Agranulocytosis | Not known |
| Anaphylactic reactions | Not known |
| Anaphylactic shock | Not known |
| Anaphylactoid reactions | Not known |
| Anaphylactoid shock | Not known |
| Angioedema (Angioneurotic oedema) (Quincke oedema) | Not known |
| Appetite lost | Not known |
| Atrioventricular block (AVB) | Uncommon |
| Bradycardia | Common |
| Bronchiolitis obliterans with organizing pneumonia | Common |
| Bronchospasm | Very rare |
| Cephalea | Very rare |
| Cerebellar ataxia | Very rare |
| Confusional state | Not known |
| Constipation | Common |
| Delirium | Not known |
| Dry cough (Non-productive cough) | Common |
| Dry mouth (Xerostomia) | Uncommon |
| Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Very Common |
| Dyspnoea exertional | Common |
| Epididymitis | Very rare |
| Fatigue | Common |
| Granuloma | Not known |
| Hallucination | Not known |
| Hepatic damage | Common |
| Hyponatraemia (Hyponatremia) | Rare |
| Inappropriate antidiuretic hormone secretion (SIADH) | Very rare |
| Interstitial pneumonitis | Common |
| Intracranial hypertension (Intracranial pressure increased) | Very rare |
| Jaundice | Common |
| Libido decreased | Not known |
| Lung disease | Common |
| Lung fibrosis interstitial | Common |
| Lupus syndrome | Not known |
| Myopathy | Uncommon |
| Nausea | Very Common |
| Neutropenia | Not known |
| Nightmares | Common |
| Pancreatitis | Not known |
| Pancreatitis acute | Not known |
| Parkinsonism | Not known |
| Parosmia | Not known |
| Peripheral sensory neuropathy | Uncommon |
| Pleurisy (Pleuritis ) | Common |
| Pulmonary haemorrhage | Not known |
| Renal disorder | Very rare |
| Serum creatinine increased | Very rare |
| Shock | Not known |
| Sinoatrial block | Uncommon |
| Sleep disorder (Sleep disturbance) | Common |
| Thrombocytopenia (Thrombopenia) | Very rare |
| Torsade de pointes | Not known |
| Transaminases increased | Very Common |
| Tremor | Common |
| Urticaria | Not known |
| Vasculitis | Very rare |
| Vomiting | Very Common |
| NB : Products With Same Indication |
Different Units By MoH Code
Farcodarone* MoH 1851 :
| Form | Tablet |
| Package Size | Box of 30 |
| Strength | 200mg |
| NSSF | ✘ |
| Quarantine | ✘ |
| Reg. Number | 208344/02 |
| Submission date | 01/01/2002 |
| Registration Year | 2002 |
| Archived Date | 2014 |
Price Comparison
- ◼ Lebanon
- ◼ Country of Origin
- ◼ Reference Countries
- ◼ Other Countries
You have to register to view this info
Upload File
Drop File
Uploading, Please wait ....
